Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

DSM staff profile

Professor Rob Walker

PositionProfessor, Mary Glendining Chair in Medicine
DepartmentDepartment of Medicine (DSM)
QualificationsMB ChB MD(Otago) FRACP FASN FAHA
Research summaryKidney health and disease
Memberships
  • Member International Society of Nephrology Nexus and Forefronts programme committee.
  • KDIGO lipid guidelines committee, CARI guidelines committee - Cardiovascular risk factors in renal disease.
  • Member CARI guidelines committee - Dialysis adequacy.
  • Honorary Secretary and Member Executive Council ASPN, with a strong interest in developing the links between Australia and New Zealand with South East Asia and the Pacific.
Clinical
  • Nephrology
  • Cardiovascular outcomes in kidney disease
  • Dialysis outcomes in the elderly
  • Acute kidney injury
  • Diabetic kidney disease

Research

Clinical research including cardiovascular risk factors associated with CKD; hypertension, obesity and inflammation; drug induced nephrotoxicity; drugs, exercise and kidney function; acute kidney injury; dialysis outcomes in the elderly.

Basic science research focused upon mechanisms of chronic interstitial fibrosis in a chronic-lithium animal model.

Funders include Health Research Council NZ, Lotteries Health, Kidney Health NZ, Otago Medical Research Foundation.

Over 180 publications.

Additional details

Director University of Otago Research Theme: The Kidney in Health and Disease.

Publications

Mafham, M. M., Staplin, N., Emberson, J., Haynes, R., Herrington, W., Reith, C., … Walker, R., … on behalf of the SHARP Collaborative Group. (2018). Prognostic utility of estimated albumin excretion rate in chronic kidney disease: Results from the Study of Heart and Renal Protection. Nephrology Dialysis Transplantation, 33(2), 257-264. doi: 10.1093/ndt/gfw396

Kalita-De Croft, P., Bedford, J. J., Leader, J. P., & Walker, R. J. (2018). Amiloride modifies the progression of lithium-induced renal interstitial fibrosis. Nephrology, 23(1), 20-30. doi: 10.1111/nep.12929

Lloyd, H., Li, G., Tomlin, A., Tilyard, M. W., Walker, R., & Schollum, J. (2018). The prevalence and risk factors for chronic kidney disease in primary health care in the Southern Region of New Zealand. Nephrology. Advance online publication. doi: 10.1111/nep.13395

Endre, Z. H., & Walker, R. J. (2017). Biomarkers of cardiovascular risk in chronic kidney disease. In C. L. Edelstein (Ed.), Biomarkers of kidney disease. (2nd ed.) (pp. 485-511). London, UK: Elsevier. doi: 10.1016/B978-0-12-803014-1.00011-X

Lovell, S., Walker, R. J., Schollum, J. B. W., Marshall, M. R., McNoe, B. M., & Derrett, S. (2017). To dialyse or delay: A qualitative study of older New Zealanders' perceptions and experiences of decision-making, with stage 5 chronic kidney disease. BMJ Open, 7(3), e014781. doi: 10.1136/bmjopen-2016-014781

Authored Book - Research

Russell, D. G., Parnell, W. R., Wilson, N. C., Faed, J. M., Ferguson, E. L., Horwath, C. C., Herbison, G. P., Nye, E. R., Reid, P., Walker, R. J., Wilson, B. D., & Tukuitonga, C. (1999). NZ Food: NZ People. Key results of the 1997 National Nutrition Survey (LINZ® Activity & Health Research Unit). Wellington: Ministry of Health, 268p.

^ Top of page

Chapter in Book - Research

Endre, Z. H., & Walker, R. J. (2017). Biomarkers of cardiovascular risk in chronic kidney disease. In C. L. Edelstein (Ed.), Biomarkers of kidney disease. (2nd ed.) (pp. 485-511). London, UK: Elsevier. doi: 10.1016/B978-0-12-803014-1.00011-X

Walker, R. J., & Endre, Z. H. (2013). Cellular mechanisms of drug nephrotoxicity. In R. J. Alpern, O. W. Moe & M. Caplan (Eds.), Seldin and Giebisch's the kidney: Physiology and pathophysiology (Vol. 2). (5th ed.) (pp. 2889-2932). London, UK: Academic Press. doi: 10.1016/B978-0-12-381462-3.00085-9

Walker, R. J., & Endre, Z. H. (2008). Cellular mechanisms of drug nephrotoxicity. In R. J. Alpern & S. C. Hebert (Eds.), Seldin and Giebisch's: The kidney: Physiology and pathophysiology (Vols. 1-2). (4th ed.) (pp. 2507-2536). Burlington, MA: Academic Press.

Walker, R. J. (1997). Nephrology and urology. In The New Zealand Knowledge Base: a Report. (pp. 54-56). Wellington: Ministry of Research, Science and Technology.

^ Top of page

Chapter in Book - Other

Kay, I. P., & Walker, R. J. (2004). Who should not go to the cathlab? In I. P. Kay, M. Sabaté & M. A. Costa (Eds.), Cardiac catheterization and percutaneous interventions. (pp. 1-7). London: Taylor & Francis Group.

^ Top of page

Journal - Research Article

Mafham, M. M., Staplin, N., Emberson, J., Haynes, R., Herrington, W., Reith, C., … Walker, R., … on behalf of the SHARP Collaborative Group. (2018). Prognostic utility of estimated albumin excretion rate in chronic kidney disease: Results from the Study of Heart and Renal Protection. Nephrology Dialysis Transplantation, 33(2), 257-264. doi: 10.1093/ndt/gfw396

Lloyd, H., Li, G., Tomlin, A., Tilyard, M. W., Walker, R., & Schollum, J. (2018). The prevalence and risk factors for chronic kidney disease in primary health care in the Southern Region of New Zealand. Nephrology. Advance online publication. doi: 10.1111/nep.13395

Kalita-De Croft, P., Bedford, J. J., Leader, J. P., & Walker, R. J. (2018). Amiloride modifies the progression of lithium-induced renal interstitial fibrosis. Nephrology, 23(1), 20-30. doi: 10.1111/nep.12929

Lovell, S., Walker, R. J., Schollum, J. B. W., Marshall, M. R., McNoe, B. M., & Derrett, S. (2017). To dialyse or delay: A qualitative study of older New Zealanders' perceptions and experiences of decision-making, with stage 5 chronic kidney disease. BMJ Open, 7(3), e014781. doi: 10.1136/bmjopen-2016-014781

Hoye, N. A., Wilson, L. C., Wilkins, G. T., Jardine, D. L., Putt, T. L., Samaranayaka, A., Schollum, J. B. W., & Walker, R. J. (2017). Endovascular renal denervation in end-stage kidney disease patients: Cardiovascular protection: A proof-of-concept study. Kidney International Reports, 2(5), 856-865. doi: 10.1016/j.ekir.2017.04.012

Herrington, W., Staplin, N., Judge, P. K., Mafham, M., Emberson, J., Haynes, R., … Walker, R., … on behalf of the SHARP Collaborative Group. (2017). Evidence for reverse causality in the association between blood pressure and cardiovascular risk in patients with chronic kidney disease. Hypertension, 69, 314-322. doi: 10.1161/hypertensionaha.116.08386

Derrett, S., Samaranayaka, A., Schollum, J. B. W., McNoe, B., Marshall, M. R., Williams, S., Wyeth, E. H., & Walker, R. J. (2017). Predictors of health deterioration among older adults after 12 months of dialysis therapy: A longitudinal cohort study from New Zealand. American Journal of Kidney Diseases, 70(6), 798-806. doi: 10.1053/j.ajkd.2017.06.023

Page, M. J., Wyeth, E. H., Samaranayaka, A., McNoe, B., Walker, R. C., Schollum, J., … Walker, R., & Derrett, S. (2017). Accuracy of ethnicity data recorded in hospital-based patient clinical records and the Australia and New Zealand Dialysis and Transplant Registry. New Zealand Medical Journal, 130(1454), 65-71. Retrieved from https://www.nzma.org.nz/journal

Obrador, G. T., Schultheiss, U. T., Kretzler, M., Langham, R. G., Nangaku, M., Pecoits-Filho, R., … Walker, R., … Köttgen, A. (2017). Genetic and environmental risk factors for chronic kidney disease. Kidney International Supplements, 7(2), 88-106. doi: 10.1016/j.kisu.2017.07.004

Stayner, C., Poole, C. A., McGlashan, S. R., Pilanthananond, M., Brauning, R., Markie, D., … Slobbe, L., … Parker, K., Wiles, A., … Leichter, A., Leask, M., … Jennings, M., Horsfield, J. A., Walker, R. J., & Eccles, M. R. (2017). An ovine hepatorenal fibrocystic model of a Meckel-like syndrome associated with dysmorphic primary cilia and TMEM67 mutations. Scientific Reports, 7, 1601. doi: 10.1038/s41598-017-01519-4

Storey, B. C., Staplin, N., Haynes, R., Reith, C., Emberson, J., Herrington, W. G., … Walker, R., … on behalf of the SHARP Collaborative Group. (2017). Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation. Kidney International. Advance online publication. doi: 10.1016/j.kint.2017.09.011

Todd, A. S., Walker, R. J., MacGinley, R. J., Kelly, J., Merriman, T. R., Major, T. J., & Johnson, R. J. (2017). Dietary sodium modifies serum uric acid concentrations in humans. American Journal of Hypertension, 30(12), 1196-1202. doi: 10.1093/ajh/hpx123

de Groot, T., Doornebal, J., Christensen, B. M., Cockx, S. C., Sinke, A. P., Baumgarten, R., Bedford, J. J., Walker, R. J., … Deen, P. M. T. (2017). Lithium-induced NDI: Acetazolamide reduces polyuria, but does not improve urine concentrating ability. American Journal of Physiology: Renal Physiology. Advance online publication. doi: 10.1152/ajprenal.00147.2017

Kuan, I. H. S., Duffull, S. B., Putt, T. L., Schollum, J. B. W., Walker, R. J., & Wright, D. F. B. (2017). A population pharmacokinetic model for 51Cr EDTA to estimate renal function. Clinical Pharmacokinetics, 56(6), 671-678. doi: 10.1007/s40262-016-0489-x

Yao, Y., Davis, G., Harrison, J. C., Walker, R. J., & Sammut, I. A. (2017). Renal functional responses in diabetic nephropathy following chronic bilateral renal denervation. Autonomic Neuroscience, 204, 98-104. doi: 10.1016/j.autneu.2016.09.019

Staplin, N., Haynes, R., Herrington, W. G., Reith, C., Cass, A., Fellström, B., … Walker, R., … on behalf of the SHARP Collaborative Group. (2016). Smoking and adverse outcomes in patients with CKD: The Study of Heart and Renal Protection (SHARP). American Journal of Kidney Diseases, 68(3), 371-380. doi: 10.1053/j.ajkd.2016.02.052

Mandic, S., Stevens, E., Hodge, C., Brown, C., Walker, R., Body, D., … Nye, E. R., & Williams, M. J. A. (2016). Long-term effects of cardiac rehabilitation in elderly individuals with stable coronary artery disease. Disability & Rehabilitation, 38(9), 837-843. doi: 10.3109/09638288.2015.1061611

Marti, H.-P., Jeffs, A., Scherer, A., Leader, J., Leader, C., Bedford, J., & Walker, R. (2016). Renal fibrosis mRNA classifier: Validation in experimental lithium-induced interstitial fibrosis in the rat kidney. PLoS ONE, 11(12), e0168240. doi: 10.1371/journal.pone.0168240

Marshall, M. R., Young, B. A., Fox, S. J., Cleland, C. J., Walker, R. J., Maskane, I., & Herold, A. M. (2015). The home hemodialysis hub: Physical infrastructure and integrated governance structure. Hemodialysis International, 19(Suppl. 1), S8-S22. doi: 10.1111/hdi.12273

Chembo, C. L., Marshall, M. R., Williams, L. C., Walker, R. J., Lynn, K. L., Irvine, J., & Pilmore, H. L. (2015). Long-term outcomes for primary glomerulonephritis: New Zealand Glomerulonephritis study. Nephrology, 20(12), 899-907. doi: 10.1111/nep.12538

Egan, R., Wood, S., MacLeod, R., & Walker, R. (2015). Spirituality in renal supportive care: A thematic review. Healthcare, 3(4), 1174-1193. doi: 10.3390/healthcare3041174

Mandic, S., Body, D., Barclay, L., Walker, R., Nye, E. R., Grace, S. L., & Williams, M. J. A. (2015). Community-based cardiac rehabilitation maintenance programs: Use and effects. Heart, Lung & Circulation, 24, 710-718. doi: 10.1016/j.hlc.2015.01.014

Flynn, T. J., Cadzow, M., Dalbeth, N., Jones, P. B., Stamp, L. K., Harré Hindmarsh, J., Todd, A. S., Walker, R. J., Topless, R., & Merriman, T. R. (2015). Positive association of tomato consumption with serum urate: Support for tomato consumption as an anecdotal trigger of gout flares. BMC Musculoskeletal Disorders, 16, 196. doi: 10.1186/s12891-015-0661-8

Bose, B., Badve, S. V., Hiremath, S. S., Boudville, N., Brown, F. G., Cass, A., … Palmer, S. C., … Walker, R. J., … Johnson, D. W. (2014). Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis. Nephrology Dialysis Transplantation, 29(2), 406-413. doi: 10.1093/ndt/gft378

Haynes, R., Staplin, N., Emberson, J., Herrington, W. G., Tomson, C., Agodoa, L., … on behalf of the SHARP Collaborative Group, including Walker, R. (2014). Evaluating the contribution of the cause of kidney disease to prognosis in CKD: Results from the Study of Heart and Renal Protection (SHARP). American Journal of Kidney Diseases, 64(1), 40-48. doi: 10.1053/j.ajkd.2013.12.013

Haynes, R., Lewis, D., Emberson, J., Reith, C., Agodoa, L., Cass, A., … Walker, R., … for the SHARP Collaborative Group. (2014). Effects of lowering LDL cholesterol on progression of kidney disease. Journal of the American Society of Nephrology, 25(8), 1825-1833. doi: 10.1681/ASN.2013090965

Weiner, I. D., Leader, J. P., Bedford, J. J., Verlander, J. W., Ellis, G., Kalita, P., Vos, F., de Jong, S., & Walker, R. J. (2014). Effects of chronic lithium administration on renal acid excretion in humans and rats. Physiological Reports, 2(12), e12242. doi: 10.14814/phy2.12242

Yao, Y., Fomison-Nurse, I. C., Harrison, J. C., Walker, R. J., Davis, G., & Sammut, I. A. (2014). Chronic bilateral renal denervation attenuates renal injury in a transgenic rat model of diabetic nephropathy. American Journal of Physiology: Renal Physiology, 307, F251-F262. doi: 10.1152/ajprenal.00578.2013

Egan, R., MacLeod, R., Tiatia, R., Wood, S., Mountier, J., & Walker, R. (2014). Spiritual care and kidney disease in NZ: A qualitative study with New Zealand renal specialists. Nephrology, 19(11), 708-713. doi: 10.1111/nep.12323

Hoye, N. A., Baldi, J. C., Putt, T. L., Schollum, J. B., Wilkins, G. T., & Walker, R. J. (2014). Endovascular renal denervation: A novel sympatholytic with relevance to chronic kidney disease. Clinical Kidney Journal, 7(1), 3-10. doi: 10.1093/ckj/sft130

Putt, T. L., Duffull, S. B., Schollum, J. B. W., & Walker, R. J. (2014). GFR may not accurately predict aspects of proximal tubule drug handling. European Journal of Clinical Pharmacology, 70(10), 1221-1226. doi: 10.1007/s00228-014-1733-7

Berney-Meyer, L., Hung, N., Slatter, T., Schollum, J. B. W., Kitching, A. R., & Walker, R. J. (2014). Omeprazole-induced acute interstitial nephritis: A possible Th1–Th17-mediated injury? Nephrology, 19(6), 359-365. doi: 10.1111/nep.12226

Herrington, W., Emberson, J., Staplin, N., Blackwell, L., Fellström, B., Walker, R., … on behalf of the SHARP Investigators. (2014). The effect of lowering LDL cholesterol on vascular access patency: Post hoc analysis of the Study of Heart and Renal Protection. Clinical Journal of the American Society of Nephrology, 9(5), 919. doi: 10.2215/CJN.10371013

Mandic, S., Hodge, C., Stevens, E., Walker, R., Nye, E. R., Body, D., Barclay, L., & Williams, M. J. A. (2013). Effects of community-based cardiac rehabilitation on body composition and physical function in individuals with stable coronary artery disease: 1.6-year followup. BioMed Research International, 2013, 903604. doi: 10.1155/2013/903604

Manning, P. J., Sutherland, W. H. F., Williams, S. M., Walker, R. J., Berry, E. A., De Jong, S. A., & Ryalls, A. R. (2013). The effect of lipoic acid and vitamin E therapies in individuals with the metabolic syndrome. Nutrition, Metabolism & Cardiovascular Diseases, 23(6), 543-549. doi: 10.1016/j.numecd.2011.11.006

Walker, R., Derrett, S., Campbell, J., Marshall, M. R., Henderson, A., Schollum, J., Williams, S., & McNoe, B. (2013). Dialysis outcomes in those aged ≥ 65 years. BMC Nephrology, 14, 175. doi: 10.1186/1471-2369-14-175

Mandic, S., Walker, R., Stevens, E., Nye, E. R., Body, D., Barclay, L., & Williams, M. J. A. (2013). Estimating exercise capacity from walking tests in elderly individuals with stable coronary artery disease. Disability & Rehabilitation, 35(22), 1853-1858. doi: 10.3109/09638288.2012.759629

Zacharias, M., Mugawar, M., Herbison, G. P., Walker, R. J., Hovhannisyan, K., Sivalingam, P., & Conlon, N. P. (2013). Interventions for protecting renal function in the perioperative period (Review). Cochrane Database of Systematic Reviews, 9, CD003590. doi: 10.1002/14651858.CD003590.pub4

Walker, R. J., Leader, J. P., Bedford, J. J., Gobe, G., Davis, G., Vos, F. E., deJong, S., & Schollum, J. B. W. (2013). Chronic interstitial fibrosis in the rat kidney induced by long-term (6-mo) exposure to lithium. American Journal of Physiology: Renal Physiology, 304(3), F300-F307. doi: 10.1152/ajprenal.00182.2012

Schollum, J. B. W., & Walker, R. J. (2012). Adult urinary tract infection. British Journal of Hospital Medicine, 73(4), 218-223.

Vos, F. E., Schollum, J. B., Coulter, C. V., Manning, P. J., Duffull, S. B., & Walker, R. J. (2012). Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology, 17(2), 182-188. doi: 10.1111/j.1440-1797.2011.01517.x

Winburn, I. C., Gunatunga, K., McKernan, R. D., Walker, R. J., Sammut, I. A., & Harrison, J. C. (2012). Cell damage following carbon monoxide releasing molecule exposure: Implications for therapeutic applications. Basic & Clinical Pharmacology & Toxicology, 111(1), 31-41. doi: 10.1111/j.1742-7843.2012.00856.x

Pickering, J. W., Frampton, C. M., Walker, R. J., Shaw, G. M., & Endre, Z. H. (2012). Four hour creatinine clearance is better than plasma creatinine for monitoring renal function in critically ill patients. Critical Care, 16, R107. doi: 10.1186/cc11391

Nejat, M., Pickering, J. W., Devarajan, P., Bonventre, J. V., Edelstein, C. L., Walker, R. J., & Endre, Z. H. (2012). Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney International, 81, 1254-1262. doi: 10.1038/ki.2012.23

Ting, Y.-T., Coates, P. T., Walker, R. J., & McLellan, A. D. (2012). Urinary tubular biomarkers as potential early predictors of renal allograft rejection. Nephrology, 17(1), 11-16. doi: 10.1111/j.1440-1797.2011.01536.x

Todd, A. S., MacGinley, R. J., Schollum, J. B. W., Williams, S. M., Sutherland, W. H. F., Mann, J. I., & Walker, R. J. (2012). Dietary sodium loading in normotensive healthy volunteers does not increase arterial vascular reactivity or blood pressure. Nephrology, 17(3), 249-256. doi: 10.1111/j.1440-1797.2011.01550.x

Berney-Meyer, L., Putt, T., Schollum, J., & Walker, R. (2012). Nephrotoxicity of recreational party drugs. Nephrology, 17(2), 99-103. doi: 10.1111/j.1440-1797.2011.01537.x

Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., … Walker, R., … on behalf of the SHARP Investigators. (2011). The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial. Lancet, 377(9784), 2181-2192. doi: 10.1016/S0140-6736(11)60739-3

Endre, Z. H., Pickering, J. W., & Walker, R. J. (2011). Clearance and beyond: The complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI). American Journal of Physiology: Renal Physiology, 301(4), F697-F707. doi: 10.1152/ajprenal.00448.2010

Korell, J., Vos, F. E., Coulter, C. V., Schollum, J. B., Walker, R. J., & Duffull, S. B. (2011). Modeling red blood cell survival data. Journal of Pharmacokinetics & Pharmacodynamics, 38(6), 797-801. doi: 10.1007/s10928-011-9220-6

Slade, H., Williams, S. M., Manning, P. J., & Walker, R. J. (2011). High-risk diabetic nephropathy patients: The outcome of evidence-based clinical practice in an outpatient clinic. Diabetes Research & Clinical Practice, 92(3), 356-360. doi: 10.1016/j.diabres.2011.02.022

Endre, Z. H., Pickering, J. W., Walker, R. J., Devarajan, P., Edelstein, C. L., Bonventre, J. V., Frampton, C. M., … Shaw, G. M., Henderson, S. J., Nejat, M., Schollum, J. B. W., & George, P. M. (2011). Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney International, 79, 1119-1130. doi: 10.1038/ki.2010.555

Bird, S. D., Legge, M., & Walker, R. J. (2011). Thiols stabilize cobblestone morphology of cultured mesothelial cells. Cell Biology International, 35(8), 857-867. doi: 10.1042/CBI20100593

Vos, F. E., Schollum, J. B., & Walker, R. J. (2011). Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney disease. NDT Plus, 4(6), 368-375. doi: 10.1093/ndtplus/sfr140

Li, P. K.-T., Cheung, W. L., Lui, S. L., Blagg, C., Cass, A., Hooi, L. S., … Walker, R., … Yu, A. W.-Y. (2011). Increasing home-based dialysis therapies to tackle dialysis burden around the world: A position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis. Hemodialysis International, 15(1), 10-14. doi: 10.1111/j.1542-4758.2010.00512.x

Vos, F. E., Schollum, J. B., Coulter, C. V., Doyle, T. C. A., Duffull, S. B., & Walker, R. J. (2011). Red blood cell survival (RBC) in patients on long-term dialysis. Nephrology, 16(Suppl. 1), 74. doi: 10.1111/j.1440-1797.2011.01493_7.x

Vos, F. E., Manning, P. J., Sutherland, W. H. F., Schollum, J. B., & Walker, R. J. (2011). Anti-inflammatory effect of an insulin infusion in patients on maintenance haemodialysis: A randomized controlled pilot study. Nephrology, 16(1), 68-75. doi: 10.1111/j.1440-1797.2010.01329.x

Vos, F. E., Schollum, J. B., Coulter, C. V., Doyle, T. C. A., Duffull, S. B., & Walker, R. J. (2011). Red blood cell survival in long-term dialysis patients. American Journal of Kidney Diseases, 58(4), 591-598. doi: 10.1053/j.ajkd.2011.03.031

Endre, Z. H., Walker, R. J., Pickering, J. W., Shaw, G. M., Frampton, C. M., Henderson, S. J., Hutchison, R., … Robinson, J. M., Schollum, J. B. W., … Celi, L. A., … George, P. M. (2010). Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney International, 77, 1020-1030. doi: 10.1038/ki.2010.25

Nejat, M., Pickering, J. W., Walker, R. J., Westhuyzen, J., Shaw, G. M., Frampton, C. M., & Endre, Z. H. (2010). Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Critical Care, 14(3), R85. doi: 10.1186/cc9014

Derrett, S., Darmody, M., Williams, S., Rutherford, M., Schollum, J., & Walker, R. (2010). Older peoples' satisfaction with home-based dialysis. Nephrology, 15(4), 464-470. doi: 10.1111/j.1440-1797.2010.01286.x

Nejat, M., Pickering, J. W., Walker, R. J., & Endre, Z. H. (2010). Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrology Dialysis Transplantation, 25, 3283-3289. doi: 10.1093/ndt/gfq176

Ting, Y. T., Coates, T. P., Marti, H. P., Dunn, A. C., Parker, R. M., Pickering, J. W., Jack, R. W., Kemp, R. A., Walker, R. J., & McLellan, A. D. (2010). Urinary soluble HLA-DR is a potential biomarker for acute renal transplant rejection. Transplantation, 89(9), 1071-1078. doi: 10.1097/TP.0b013e3181d15492

SHARP Collaborative Group, including Walker, R. (2010). Study of Heart and Renal Protection (SHARP): Randomized trial to access the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. American Heart Journal, 160(5), 785-794 e10. doi: 10.1016/j.ahj.2010.08.012

Todd, A. S., MacGinley, R. J., Schollum, J. B. W., Johnson, R. J., Williams, S. M., Sutherland, W. H. F., Mann, J. I., & Walker, R. J. (2010). Dietary salt loading impairs arterial vascular reactivity. American Journal of Clinical Nutrition, 91(3), 557-564. doi: 10.3945/ajcn.2009.28645

Bird, S. D., Walker, R. J., & Legge, M. (2009). L-Cysteine improves survival and growth of mesothelial cells after freezing. Cell Biology International, 33(11), 1155-1164. doi: 10.1016/j.cellbi.2009.08.003

Manning, P. J., Sutherland, W. H. F., Walker, R. J., Williams, S. M., de Jong, S. A., & Berry, E. A. (2008). The effect of rosiglitazone on oxidative stress and insulin resistance in overweight individuals. Diabetes Research & Clinical Practice, 81, 209-215.

Bedford, J. J., Leader, J. P., Jing, R., Walker, L. J., Klein, J. D., Sands, J. M., & Walker, R. J. (2008). Amiloride restores renal medullary osmolytes in lithium-induced nephrogenic diabetes insipidus. American Journal of Physiology: Renal Physiology, 294, F812-F820. doi: 10.1152/ajprenal.00554.2007

Lucas, S. J. E., Anglem, N., Roberts, W. S., Anson, J. G., Palmer, C. D., Walker, R. J., … Cotter, J. D. (2008). Intensity and physiological strain of competitive ultra-endurance exercise in humans. Journal of Sports Sciences, 26(5), 477-489.

Bedford, J. J., Weggery, S., Ellis, G., McDonald, F. J., Joyce, P. R., Leader, J. P., & Walker, R. J. (2008). Lithium-induced nephrogenic diabetes insipidus: Renal effects of amiloride. Clinical Journal of the American Society of Nephrology, 3(5), 1324-1331.

Zacharias, M., Conlon, N. P., Herbison, G. P., Sivalingam, P., Walker, R. J., & Hovhannisyan, K. (2008). Interventions for protecting renal function in the perioperative period (Review). Cochrane Database of Systematic Reviews, 4, CD003590. doi: 10.1002/14651858.CD003590.pub3

Manning, P. J., Sutherland, W. H. F., Walker, R. J., de Jong, S. A., & Berry, E. A. (2008). The effect of glucose ingestion on inflammation and oxidative stress in obese individuals. Metabolism, 57, 1345-1349.

Merry, T. L., Ainslie, P. N., Walker, R., & Cotter, J. D. (2008). Fitness alters fluid regulatory but not behavioural responses to hypohydrated exercise. Physiology & Behavior, 95(3), 348-352.

Khan, E., Huggan, P., Celi, L., MacGinley, R., Schollum, J., & Walker, R. (2008). Sustained low-efficiency dialysis with filtration (SLEDD-f) in the management of acute sodium valproate intoxication. Hemodialysis International, 12(2), 211-214.

Manning, P. J., Sutherland, W. H. F., McGrath, M. M., de Jong, S. A., Walker, R. J., & Williams, M. J. A. (2008). Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity, 16(9), 2046-2052. doi: 10.1038/oby.2008.334

Kerr, P. G., Sutherland, W. H. F., de Jong, S., Vaithalingham, I., Williams, S. M., & Walker, R. J. (2007). The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: A randomized, single-blinded, controlled clinical trial. American Journal of Kidney Diseases, 49(4), 533-539. doi: 10.1053/j.ajkd.2006.12.019

Sutherland, W. H. F., Manning, P. J., Walker, R. J., de Jong, S. A., Ryalls, A. R., & Berry, E. A. (2007). Vitamin E supplementation and plasma 8-isoprostane and adiponectin in overweight subjects. Obesity, 15(2), 386-391. doi: 10.1038/oby.2007.546

Bradford, C. D., Cotter, J. D., Thorburn, M. S., Walker, R. J., & Gerrard, D. F. (2007). Exercise can be pyrogenic in humans. American Journal of Physiology: Regulatory, Integrative & Comparative Physiology, 292, R143-R149. doi: 10.1152/ajpregu.00926.2005

Wilson, J. C., Yoon, H.-S., Walker, R. J., & Eccles, M. R. (2007). A novel Cys1638Tyr NC1 domain substitution in α5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities. Nephrology Dialysis Transplantation, 22(5), 1338-1346. doi: 10.1093/ndt/gfl793

Sutherland, W. H. F., de Jong, S. A., & Walker, R. J. (2007). Effect of dietary cholesterol and fat on cell cholesterol transfer to postprandial plasma in hyperlipidemic men. Lipids, 42, 901-911. doi: 10.1007/s11745-007-3101-1

Zoungas, S., McGrath, B. P., Branley, P., . . ., Walker, R., & McNeil, J. J. (2006). Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure. JACC, 47(6), 1108-1116.

Walker, R. J., Weggery, S., Bedford, J. J., McDonald, F. J., Ellis, G., & Leader, J. P. (2005). Lithium-induced reduction in urinary concentrating ability and urinary aquaporin 2 (AQP2) excretion in healthy volunteers. Kidney International, 67, 291-294.

Walker, R. (2005). Cardiovascular risk factors: Lipid-lowering therapy in patients with chronic kidney disease. Nephrology, 10, S231-S234.

Baker, J., Cotter, J. D., Gerrard, D. F., Bell, M. L., & Walker, R. J. (2005). Effects of indomethacin and celecoxib on renal function in athletes. Medicine & Science in Sports & Exercise, 37(5), 712-717.

Thomas, M., Blennerhassett, J., & Walker, R. (2005). Relapse with transformation of lupus nephritis in a transplant kidney [Case report]. Lupus, 14, 554-556.

Zacharias, M., Gilmore, I. C. S., Herbison, G. P., Sivalingam, P., & Walker, R. J. (2005). Interventions for protecting renal function in the perioperative period (Review). Cochrane Database of Systematic Reviews, 3. doi: 10.1002/14651858.CD003590.pub2

Sutherland, W. H. F., de Jong, S. A., & Walker, R. J. (2005). Hypochlorous acid and 3,4-dihydroxyphenylalanine increase the formation of serum protein lipofuscin-like fluorophores in vitro. Renal Failure, 27, 239-246.

Tong, D. C., & Walker, R. J. (2004). Antibiotic prophylaxis in dialysis patients undergoing invasive dental treatment. Nephrology, 9, 167-170.

Roger, S. D., McMahon, L. P., Clarkson, A., Disney, A., Harris, D., Hawley, C., … Lynn, K., … Walker, R., & Levin, A. (2004). Effects of early and late intervention with epoetin α on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): Results of a randomized clinical trial. Journal of the American Society of Nephrology, 15, 148-156.

Walker, R. J., Sutherland, W. H., & De Jong, S. A. (2004). Effect of changing from a cellulose acetate to a polysulphone dialysis membrane on protein oxidation and inflammation markers. Clinical Nephrology, 61(3), 198-206. doi: 10.5414/CNP61198

Manning, P. J., Sutherland, W. H., Walker, R. J., Williams, S. M., de Jong, S. A., Ryalls, A. R., & Berry, E. A. (2004). Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects. Diabetes Care, 27(9), 2166-2171.

McMahon, L. P., Roger, S. D., Levin, A., for the Slimheart Investigators Group, including Walker, R. J. (2004). Development, prevention, and potential reversal of left ventricular hypertrophy in chronic kidney disease. Journal of the American Society of Nephrology, 15, 1640-1647.

Bird, S. D., Legge, M., & Walker, R. J. (2004). Formaldehyde scavenging from peritoneal dialysis solutions using reduced aminothiol compounds. Nephrology, 9, 65-72.

Zoungas, S., Branley, P., Kerr, P. G., Ristevski, S., Muske, C., Demos, L., … Walker, R., … McGrath, B. P. (2004). Atherosclerosis and folic acid supplementation trial in chronic renal failure: Baseline results. Nephrology, 9, 130-141.

More publications...